GlassScriptPhysician profile
Neil Q Tran
NPI 1316096688
$28,442.24
in general payments reported to CMS, 2019-2025
59 companies · $2,648 in 2025
The $2,648 reported for 2025 was more than what 81% of Endocrinology, Diabetes & Metabolism providers received nationally (typical 2025 total: $506).
See the full distribution for Endocrinology, Diabetes & Metabolism
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $13K · 2020: $1,753 · 2021: $2,625 · 2022: $1,527 · 2023: $3,853 · 2024: $2,569 · 2025: $2,648.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $7,185 · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $1,800 · Education: $85.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $7,185.46 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $1,800.00 |
| Education | $85.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $11,125.96 | 2019-2025 | Synthroid, Ubrelvy |
| Horizon Therapeutics Plc | $4,745.68 | 2019-2022 | |
| Lilly USA, LLC | $1,758.65 | 2019-2025 | Mounjaro, Jardiance, Trulicity |
| Novo Nordisk INC | $1,383.59 | 2019-2025 | Wegovy, Ozempic, Rybelsus |
| Amgen INC. | $1,256.68 | 2019-2025 | Evenity, Prolia, Repatha |
| Abbott Laboratories | $903.58 | 2019-2025 | Freestyle Libre 3 |
| Insulet Corporation | $864.91 | 2019-2025 | Omnipod |
| Sanofi-Aventis U.S. LLC | $602.64 | 2019-2025 | |
| Astrazeneca Pharmaceuticals LP | $564.10 | 2019-2025 | Airsupra, Farxiga |
| Radius Health, INC. | $466.63 | 2020-2025 | Tymlos |
| Boehringer Ingelheim Pharmaceuticals, INC. | $347.90 | 2019-2025 | Jardiance |
| Corcept Therapeutics | $324.87 | 2019-2025 | Korlym |
| Mannkind Corporation | $285.82 | 2019-2025 | |
| Regeneron Healthcare Solutions, INC. | $263.56 | 2019-2025 | Evkeeza |
| Dexcom, INC. | $236.44 | 2019-2025 | Dexcom G6 Transmitter |
Show all 59 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Recordati_rare_diseases_inc. | $204.05 | 2023-2025 | Isturisa, Signifor Lar |
| Janssen Pharmaceuticals, INC | $198.78 | 2019-2020 | |
| Xeris Pharmaceuticals, INC. | $177.27 | 2022-2025 | Recorlev, Gvoke Hypopen |
| Bayer Healthcare Pharmaceuticals INC. | $173.09 | 2021-2025 | |
| Kyowa Kirin, INC. | $171.81 | 2023-2025 | |
| Novartis Pharmaceuticals Corporation | $165.42 | 2023-2025 | |
| Tandem Diabetes Care, INC. | $159.99 | 2023-2025 | T:Slim X2 Insulin Pump With Control-Iq |
| Merck Sharp & Dohme LLC | $159.16 | 2019-2025 | Gardasil 9, Capvaxive |
| Verity Pharmaceuticals INC. | $144.60 | 2024-2025 | Tlando |
| Embecta Corp. | $128.84 | 2023-2024 | Bd Nano 2nd Gen Pen Needle |
| Ascendis Pharma Endocrinology INC | $105.45 | 2023-2025 | Yorvipath |
| Alexion Pharmaceuticals, INC. | $104.12 | 2019-2025 | Strensiq |
| Ibsa Pharma INC. | $100.93 | 2019-2022 | |
| Exact Sciences Corporation | $95.54 | 2024-2025 | Cologuard Collection Kit |
| Amarin Pharma, INC. | $82.99 | 2019-2020 | |
| Nalpropion Pharmaceuticals LLC | $79.09 | 2019 | |
| Amneal Pharmaceuticals LLC | $58.96 | 2019 | |
| Cequr Corporation | $55.85 | 2022-2024 | Cequr Simplicity |
| Antares Pharma, INC. | $54.32 | 2024-2025 | Xyosted |
| Beta Bionics, INC. | $53.86 | 2023-2024 | Ilet Bionic Pancreas |
| Currax Pharmaceuticals LLC | $52.26 | 2021-2024 | Contrave, Nexletol, Nexlizet |
| Zealand Pharma US, INC. | $50.56 | 2021-2022 | |
| Chiesi USA, INC. | $49.37 | 2025 | Myalept |
| Ipsen Biopharmaceuticals, INC | $47.92 | 2019 | |
| Medtronic, INC. | $46.45 | 2023-2024 | Minimed 780g |
| Kowa Pharmaceuticals America, INC. | $46.16 | 2019 | |
| Tolmar, INC. | $45.70 | 2023-2025 | Jatenzo |
| Averitas Pharma INC. | $43.22 | 2025 | Qutenza |
| Halozyme INC | $43.06 | 2023 | |
| Shire North American Group INC | $39.36 | 2019 | |
| Madrigal Pharmaceuticals | $39.35 | 2025 | Rezdiffra |
| Arbor Pharmaceuticals, INC. | $38.77 | 2019-2020 | |
| Glaxosmithkline, LLC. | $37.32 | 2024 | Shingrix, Arexvy |
| Medtronic Minimed, INC. | $33.77 | 2019-2020 | |
| Eisai INC. | $32.85 | 2019 | |
| Alvogen INC | $29.86 | 2023-2024 | Teriparatide |
| Pfizer INC. | $26.33 | 2019-2021 | |
| Rhythm Pharmaceuticals, INC. | $24.96 | 2025 | Imcivree |
| Lifescan, INC. | $23.37 | 2020 | |
| Valeritas, INC. | $21.74 | 2019 | |
| Sequel Med Tech, LLC | $20.34 | 2025 | Twiist |
| Ascend Therapeutics US, LLC | $17.61 | 2021 | |
| Acella Pharmaceuticals, LLC | $14.03 | 2023 | NP Thyroid 60 |
| Esperion Therapeutics, INC. | $12.75 | 2023 | Nexletol |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Neil Tran listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.